Status:

UNKNOWN

A Trial of SHR-1701 in Combination With and Without Famitinib Malate in Patients With Extensive Stage Small Cell Lung Cancer

Lead Sponsor:

Jiangsu HengRui Medicine Co., Ltd.

Conditions:

Lung Cancer

Eligibility:

All Genders

18-75 years

Phase:

PHASE2

Brief Summary

The study is being conducted to evaluate the efficacy and safety of SHR-1701 in combination with or without famitinib malate for the treatment of extensive stage small cell lung cancer after the failu...

Eligibility Criteria

Inclusion

  • Patients voluntarily participated in the clinical study, understood the study procedures and are able to sign the informed consent form.
  • 18 to 75 years old, male or female.
  • Histologically or cytologically confirmed extensive stage small cell lung cancer(ED-SCLC).
  • ECOG Performance Status of 0 or 1.
  • Adequate hematological, hepatic and renal function.
  • Female subjects of child-bearing potential must have a negative serum HCG test before treatment.

Exclusion

  • Histologically or cytologically confirmed mixed SCLC and NSCLC.
  • Untreated central nervous system metastases.
  • Cancerous meningitis (meningeal metastasis).
  • Uncontrolled pleural effusion, pericardial effusion or ascites.
  • Tumor infiltration into the great vessels on imaging;
  • Hemoptysis symptoms and maximum daily hemoptysis ≥ 2.5ml occurred within 1 month.
  • Uncontrolled tumor-related pain.
  • Malignancies other than SCLC within 5 years.
  • Systemic antitumor therapy was received 4 weeks prior to trial treatment.
  • History of autoimmune diseases.
  • Significant cardiovascular disease.
  • Inadequately controlled hypertension.
  • Known history of testing positive test for HIV or known AIDS.
  • Patients with active hepatitis B or hepatitis C
  • Severe infections within 4 weeks prior to trial treatment.
  • Active tuberculosis.

Key Trial Info

Start Date :

May 31 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2022

Estimated Enrollment :

106 Patients enrolled

Trial Details

Trial ID

NCT04884009

Start Date

May 31 2021

End Date

December 31 2022

Last Update

May 12 2021

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.